tiprankstipranks
Advertisement
Advertisement

ATXS Stock Latest News

Is ATXS a Buy, Before Earnings?
Pre-EarningsIs ATXS a Buy, Before Earnings?
3M ago
ATXS
One new option listing and one option delisting on January 26th
PremiumThe Fly
One new option listing and one option delisting on January 26th
4M ago
ATXS
BANX
Astria Therapeutics Completes Merger and Goes Private
PremiumCompany Announcements
Astria Therapeutics Completes Merger and Goes Private
4M ago
8K
ATXS
BioCryst completes acquisition of Astria Therapeutics
PremiumThe Fly
BioCryst completes acquisition of Astria Therapeutics
4M ago
ATXS
BCRX
Astria Shareholders Approve Acquisition by BioCryst Pharmaceuticals
PremiumCompany Announcements
Astria Shareholders Approve Acquisition by BioCryst Pharmaceuticals
4M ago
8K
ATXS
Astria stockholders vote to approve acquisition by BioCryst
PremiumThe FlyAstria stockholders vote to approve acquisition by BioCryst
4M ago
ATXS
BCRX
Astria Faces Shareholder Lawsuits Over Planned BioCryst Merger
Premium
Company Announcements
Astria Faces Shareholder Lawsuits Over Planned BioCryst Merger
5M ago
8K
ATXS
BioCryst receives early termination of HSR waiting period for Astria acquisition
Premium
The Fly
BioCryst receives early termination of HSR waiting period for Astria acquisition
6M ago
ATXS
BCRX
Astria Therapeutics Reports Q3 2025 Results and BioCryst Acquisition
PremiumCompany Announcements
Astria Therapeutics Reports Q3 2025 Results and BioCryst Acquisition
7M ago
ATXS
Astria Therapeutics: Hold Rating Amid Acquisition and Financial Stability with Future Growth Prospects
PremiumRatings
Astria Therapeutics: Hold Rating Amid Acquisition and Financial Stability with Future Growth Prospects
7M ago
ATXS
Astria Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe Fly
Astria Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
7M ago
ATXS
Is ATXS a Buy, Before Earnings?
PremiumPre-Earnings
Is ATXS a Buy, Before Earnings?
7M ago
ATXS
Astria Therapeutics announces final results from ALPHA-STAR trial
PremiumThe FlyAstria Therapeutics announces final results from ALPHA-STAR trial
7M ago
ATXS
Astria Therapeutics Advances Phase 3 Trial for Hereditary Angioedema Treatment
Premium
Company Announcements
Astria Therapeutics Advances Phase 3 Trial for Hereditary Angioedema Treatment
7M ago
ATXS
Astria Therapeutics Advances Phase 3 Trial for Hereditary Angioedema Treatment
Premium
Company Announcements
Astria Therapeutics Advances Phase 3 Trial for Hereditary Angioedema Treatment
7M ago
ATXS
Astria Therapeutics’ STAR-0310 Study: A Promising Step Forward
PremiumCompany Announcements
Astria Therapeutics’ STAR-0310 Study: A Promising Step Forward
7M ago
ATXS
Astria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Astria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
8M ago
ATXS
BioCryst price target raised to $26 from $24 at Cantor Fitzgerald
PremiumThe Fly
BioCryst price target raised to $26 from $24 at Cantor Fitzgerald
8M ago
ATXS
BCRX
Astria Therapeutics downgraded to Neutral from Outperform at Wedbush
PremiumThe Fly
Astria Therapeutics downgraded to Neutral from Outperform at Wedbush
8M ago
ATXS
BioCryst price target raised to $27 from $17 at Citizens JMP
PremiumThe FlyBioCryst price target raised to $27 from $17 at Citizens JMP
8M ago
ATXS
BCRX
Astria downgraded to Market Perform from Outperform at Citizens JMP
Premium
The Fly
Astria downgraded to Market Perform from Outperform at Citizens JMP
8M ago
ATXS
BioCryst reinstated with a Buy at TD Cowen
Premium
The Fly
BioCryst reinstated with a Buy at TD Cowen
8M ago
ATXS
BCRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >